Dr Reddys Laboratories (RDY) Operating Income (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Operating Income of $215.0 million for Q2 2023, up 1.42% quarter-over-quarter from $212.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Operating Income (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Operating Income history runs 15 years deep, the most recent figure standing at $215.0 million for Q2 2023.
- In Q2 2023, Operating Income changed N/A year-over-year to $215.0 million; the TTM figure through Jun 2023 stood at $200000.6 billion (changed N/A YoY), while the FY2026 annual figure was $539.0 million, down 35.99% from the prior year.
- Operating Income for Q2 2023 stood at $215.0 million, up from $212.0 million in the prior quarter.
- The five-year high for Operating Income was $200000.0 billion in Q3 2022, with the low at -$82.0 million in Q3 2019.
- The 5-year median for Operating Income is $113.0 million (2019), against an average of $16666.8 billion.
- Peak annual rise in Operating Income reached 69.7% in 2019, while the deepest fall reached 198.8% in 2019.
- Dr Reddys Laboratories' Operating Income stood at -$82.0 million in 2019, then increased by 2.44% to -$80.0 million in 2020, then surged by 303.75% to $163.0 million in 2021, then retreated by 7.36% to $151.0 million in 2022, then soared by 42.38% to $215.0 million in 2023.
- Business Quant data shows RDY's Operating Income at $215.0 million in Q2 2023, $212.0 million in Q1 2023, and $151.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 215.00 Mn |
| Mar 31, 2023 | 212.00 Mn |
| Dec 31, 2022 | 151.00 Mn |
| Sep 30, 2022 | 200,000.00 Bn |
| Jun 30, 2021 | 163.00 Mn |
| Mar 31, 2021 | 89.00 Mn |
| Sep 30, 2020 | -80.00 Mn |
| Jun 30, 2020 | 114.00 Mn |
| Mar 31, 2020 | 110.00 Mn |
| Sep 30, 2019 | -82.00 Mn |
| Jun 30, 2019 | 103.00 Mn |
| Mar 31, 2019 | 112.00 Mn |
| Dec 31, 2018 | 77.00 Mn |
| Sep 30, 2018 | 83.00 Mn |
| Jun 30, 2018 | 70.00 Mn |
| Mar 31, 2018 | 66.00 Mn |
| Dec 31, 2017 | 39.00 Mn |
| Sep 30, 2017 | 77.00 Mn |
| Dec 31, 2016 | 78.00 Mn |
| Sep 30, 2016 | 112.00 Mn |